The DOI matches its Crossref record; 165 of the 165 references it cites were found in a registry or an index.
Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors
Open accessAbstract
Nanotechnology has recently gained increased attention for its capability to effectively diagnose and treat various tumors. Nanocarriers have been used to circumvent the problems associated with conventional antitumor drug delivery systems, including their nonspecificity, severe side effects, burst release and damaging the normal cells. Nanocarriers improve the bioavailability and therapeutic efficiency of antitumor drugs, while providing preferential accumulation at the target site. A number of nanocarriers have been developed; however, only a few of them are clinically approved for the delivery of antitumor drugs for their intended actions at the targeted sites. The present review is divided into three main parts: first part presents introduction of various nanocarriers and their relevance in the delivery of anticancer drugs, second part encompasses targeting mechanisms and surface functionalization on nanocarriers and third part covers the description of selected tumors, including breast, lungs, colorectal and pancreatic tumors, and applications of relative nanocarriers in these tumors. This review increases the understanding of tumor treatment with the promising use of nanotechnology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Helical microtubules of graphitic carbon
Iijima, S. (1991) · Nature · doi:10.1038/354056a0 · Cited by 43,098
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
Siegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Conroy, T., Desseigne, F., Ychou, M., Bouché, O., Guimbaud, R., Bécouarn, Y., Adenis, A., Raoul, J.-L., Gourgou-Bourgade, S., de la Fouchardière, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011923 · Cited by 7,810
Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Doxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792
Cancer nanotechnology: opportunities and challenges
Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558
Solid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759
Delivering nanomedicine to solid tumors
Jain, R. K., & Stylianopoulos, T. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.139 · Cited by 3,180
Solid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,150
Danhier, F., Feron, O., & Préat, V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.027 · Cited by 2,800
Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers☆
SLOWING, I., VIVEROESCOTO, J., WU, C., & LIN, V (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.012 · Cited by 2,653
Vincent, A., Herman, J., Schulick, R., Hruban, R. H., & Goggins, M. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62307-0 · Cited by 2,586
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Davis, M. E., Zuckerman, J. E., Choi, C. H. J., Seligson, D., Tolcher, A., Alabi, C. A., Yen, Y., Heidel, J. D., & Ribas, A. (2010) · Nature · doi:10.1038/nature08956 · Cited by 2,505
Drug delivery with carbon nanotubes for in vivo cancer treatment
Liu, Z., Chen, K., Davis, C. R., Sherlock, S. P., Cao, Q., Chen, X. S., & Dai, H. (2008) · PubMed · doi:10.48550/arxiv.0808.2070 · Cited by 2,286
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403036 · Cited by 2,164
A review of stimuli-responsive nanocarriers for drug and gene delivery
Ganta, S., Devalapally, H., Shahiwala, A., & Amiji, M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.017 · Cited by 2,155
Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00118-7 · Cited by 2,113
Tumor delivery of macromolecular drugs based on the EPR effect
Torchilin, V. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.03.011 · Cited by 2,032
Matrix metalloproteinases and tumor metastasis
Deryugina, E. I., & Quigley, J. P. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-7886-9 · Cited by 1,960
Targeted drug delivery to tumors: Myths, reality and possibility
Bae, Y. H., & Park, K. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.06.001 · Cited by 1,935
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Pérez-Herrero, E., & Fernández-Medarde, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.018 · Cited by 1,875
Polymer nanoparticles: Preparation techniques and size-control parameters
Rao, J. P., & Geckeler, K. E. (2011) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2011.01.001 · Cited by 1,725
Ligand-targeted therapeutics in anticancer therapy
Allen, T. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc903 · Cited by 1,647
Nanoparticle Delivery of Cancer Drugs
Wang, A. Z., Langer, R., & Farokhzad, O. C. (2012) · Annual Review of Medicine · doi:10.1146/annurev-med-040210-162544 · Cited by 1,561
Glycolysis inhibition for anticancer treatment
Pelicano, H., Martin, D. S., Xu, R.-H., & Huang, P. (2006) · Oncogene · doi:10.1038/sj.onc.1209597 · Cited by 1,516
Targeted drug delivery via the folate receptor
Sudimack, J., & Lee, R. J. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00062-9 · Cited by 1,474
Drug Delivery with Carbon Nanotubes for In vivo Cancer Treatment
Liu, Z., Chen, K., Davis, C., Sherlock, S., Cao, Q., Chen, X., & Dai, H. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1468 · Cited by 1,348
Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer
Malam, Y., Loizidou, M., & Seifalian, A. M. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.08.004 · Cited by 1,318
Diagnosing lung cancer in exhaled breath using gold nanoparticles
Peng, G., Tisch, U., Adams, O., Hakim, M., Shehada, N., Broza, Y. Y., Billan, S., Abdah-Bortnyak, R., Kuten, A., & Haick, H. (2009) · Nature Nanotechnology · doi:10.1038/nnano.2009.235 · Cited by 1,263
Mesoporous silica nanoparticles in drug delivery and biomedical applications
Wang, Y., Zhao, Q., Han, N., Bai, L., Li, J., Liu, J., Che, E., Hu, L., Zhang, Q., Jiang, T., et al. (2015) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2014.09.014 · Cited by 1,192
Advances in understanding cancer genomes through second-generation sequencing
Meyerson, M., Gabriel, S., & Getz, G. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2841 · Cited by 1,116
Bonadonna, G., Valagussa, P., Moliterni, A., Zambetti, M., & Brambilla, C. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504063321401 · Cited by 1,049
Von Hoff, D. D., Ramanathan, R. K., Borad, M. J., Laheru, D. A., Smith, L. S., Wood, T. E., Korn, R. L., Desai, N., Trieu, V., Iglesias, J. L., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.5742 · Cited by 1,044
Mesoporous Silica Nanoparticles as a Delivery System for Hydrophobic Anticancer Drugs
Lu, J., Liong, M., Zink, J. I., & Tamanoi, F. (2007) · Small · doi:10.1002/smll.200700005 · Cited by 1,012
Physical stimuli-responsive polymeric micelles for anti-cancer drug delivery
Rapoport, N. (2007) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.05.009 · Cited by 1,002
Xia, T., Kovochich, M., Liong, M., Meng, H., Kabehie, S., George, S., Zink, J. I., & Nel, A. E. (2009) · ACS Nano · doi:10.1021/nn900918w · Cited by 933
Bhirde, A. A., Patel, V., Gavard, J., Zhang, G., Sousa, A. A., Masedunskas, A., Leapman, R. D., Weigert, R., Gutkind, J. S., & Rusling, J. F. (2009) · ACS Nano · doi:10.1021/nn800551s · Cited by 853
Nanoparticles for drug delivery in cancer treatment
Haley, B., & Frenkel, E. (2008) · Urologic Oncology: Seminars and Original Investigations · doi:10.1016/j.urolonc.2007.03.015 · Cited by 791
Mishra, B., Patel, B. B., & Tiwari, S. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2009.04.008 · Cited by 771
Targeted pharmaceutical nanocarriers for cancer therapy and imaging
Torchilin, V. P. (2007) · The AAPS Journal · doi:10.1208/aapsj0902015 · Cited by 762
Dhar, S., Liu, Z., Thomale, J., Dai, H., & Lippard, S. J. (2008) · Journal of the American Chemical Society · doi:10.1021/ja803036e · Cited by 700
Stiriba, S.-E., Frey, H., & Haag, R. (2002) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20020415)41:8<1329::aid-anie1329>3.0.co;2-p · Cited by 672
Current Trends in The Use of Liposomes for Tumor Targeting
Deshpande, P. P., Biswas, S., & Torchilin, V. P. (2013) · Nanomedicine · doi:10.2217/nnm.13.118 · Cited by 657
Lee, C. C., Gillies, E. R., Fox, M. E., Guillaudeu, S. J., Fréchet, J. M. J., Dy, E. E., & Szoka, F. C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607705103 · Cited by 650
Nanotechnology in Therapeutics: A Focus on Nanoparticles as A Drug Delivery System
Bamrungsap, S., Zhao, Z., Chen, T., Wang, L., Li, C., Fu, T., & Tan, W. (2012) · Nanomedicine · doi:10.2217/nnm.12.87 · Cited by 606
Wang, H., Zhao, Y., Wu, Y., Hu, Y.-L., Nan, K., Nie, G., & Chen, H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.07.032 · Cited by 603
Viruses: Making Friends with Old Foes
Douglas, T., & Young, M. (2006) · Science · doi:10.1126/science.1123223 · Cited by 601
Neri, D., & Bicknell, R. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1627 · Cited by 600
Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles☆
WONG, H., BENDAYAN, R., RAUTH, A., LI, Y., & WU, X. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.008 · Cited by 578
Development of the polymer micelle carrier system for doxorubicin
Nakanishi, T., Fukushima, S., Okamoto, K., Suzuki, M., Matsumura, Y., Yokoyama, M., Okano, T., Sakurai, Y., & Kataoka, K. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00341-8 · Cited by 570
Aptamer-functionalized PEG–PLGA nanoparticles for enhanced anti-glioma drug delivery
Guo, J., Gao, X., Su, L., Xia, H., Gu, G., Pang, Z., Jiang, X., Yao, L., Chen, J., & Chen, H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.07.004 · Cited by 566
Hamaguchi, T., Matsumura, Y., Suzuki, M., Shimizu, K., Goda, R., Nakamura, I., Nakatomi, I., Yokoyama, M., Kataoka, K., & Kakizoe, T. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602479 · Cited by 565
Nanoparticle-assisted Combination Therapies for Effective Cancer Treatment
Hu, C.-M. J., Aryal, S., & Zhang, L. (2010) · Therapeutic Delivery · doi:10.4155/tde.10.13 · Cited by 564
A PEGylated dendritic nanoparticulate carrier of fluorouracil
Bhadra, D., Bhadra, S., Jain, S., & Jain, N. K. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00132-7 · Cited by 544
Üner, M., & Yener, G. (2007) · PubMed Central · Cited by 543
Zhang, X., Meng, L., Lu, Q., Fei, Z., & Dyson, P. J. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.07.025 · Cited by 536
Biodegradable poly(ε-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen
Chawla, J. S., & Amiji, M. M. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00483-0 · Cited by 487
Functionalized carbon nanotubes: biomedical applications
Singh, S., Vardharajula, S., Tiwari, P., Eroğlu, E., Vig, K., Dennis, V., & Ali (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s35832 · Cited by 485
Recent advances in polymeric micelles for anti-cancer drug delivery
Biswas, S., Kumari, P., Lakhani, P. M., & Ghosh, B. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.12.031 · Cited by 471
Liposome-based drug delivery in breast cancer treatment
Park, J. W. (2002) · Breast Cancer Research · doi:10.1186/bcr432 · Cited by 469
Lipid‐based nanotherapeutics for siRNA delivery
Schroeder, A., Levins, C. G., Cortez, C., Langer, R., & Anderson, D. G. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02189.x · Cited by 447
Polymeric nanoparticles for targeted treatment in oncology: current insights
Joshi, M. D., Patravale, V., & Prabhu, R. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s56932 · Cited by 438
Virus-based nanocarriers for drug delivery
Ma, Y., Nolte, R. J. M., & Cornelissen, J. J. L. M. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.01.005 · Cited by 422
Dendrimer-platinate: a novel approach to cancer chemotherapy.
Malik, N., Evagorou, E. G., & Duncan, R. (1999) · PubMed · Cited by 417
Taratula, O., Kuzmov, A., Shah, M., Garbuzenko, O. B., & Minko, T. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.04.018 · Cited by 416
Dendrimers and Dendrons: Concepts, Syntheses, Applications
Newkome, G. R., Moorefield, C. N., & Vögtle, F. (2001) · Cited by 382
A new era of cancer treatment: carbon nanotubes as drug delivery tools
Seifalian, A. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s16923 · Cited by 366
Nanoparticle Technologies for Cancer Therapy
Alexis, F., Pridgen, E. M., Langer, R., & Farokhzad, O. C. (2010) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-00477-3_2 · Cited by 364
Nanotechnology-based approaches in anticancer research
Kamal, M. A., Jabir NR, N., Tabrez, Ashraf, Shakil, & Damanhouri (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s33838 · Cited by 363
Lichter, A. S., Lippman, M. E., Danforth, D. N., d'Angelo, T., Steinberg, S. M., deMoss, E., MacDonald, H. D., Reichert, C. M., Merino, M., & Swain, S. M. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.6.976 · Cited by 347
Does a targeting ligand influence nanoparticle tumor localization or uptake?
Pirollo, K. F., & Chang, E. H. (2008) · Trends in Biotechnology · doi:10.1016/j.tibtech.2008.06.007 · Cited by 347
Shenoy, D. B., & Amiji, M. M. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.12.010 · Cited by 331
Lee, G. Y., Qian, W. P., Wang, L., Wang, Y. A., Staley, C. A., Satpathy, M., Nie, S., Mao, H., & Yang, L. (2013) · ACS Nano · doi:10.1021/nn3043463 · Cited by 324
Patil, Y., Sadhukha, T., Ma, L., & Panyam, J. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.01.021 · Cited by 317
Virus-based nanoparticles (VNPs): Platform technologies for diagnostic imaging☆
MANCHESTER, M., & SINGH, P. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.014 · Cited by 292
Abou-Alfa, G. K., Letourneau, R., Harker, G., Modiano, M., Hurwitz, H., Tchekmedyian, N. S., Feit, K., Ackerman, J., De Jager, R. L., Eckhardt, S. G., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.0201 · Cited by 282
Targeting carbon nanotubes against cancer
Fabbro, C., Ali-Boucetta, H., Ros, T. D., Kostarelos, K., Bianco, A., & Prato, M. (2012) · Chemical Communications · doi:10.1039/c2cc17995d · Cited by 281
YUAN, H., MIAO, J., DU, Y., YOU, J., HU, F., & ZENG, S. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.07.012 · Cited by 275
Hollow Mesoporous Silica Nanoparticles with Tunable Structures for Controlled Drug Delivery
Li, Y., Li, N., Pan, W., Yu, Z., Yang, L., & Tang, B. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b13876 · Cited by 270
Tseng, C.-L., Su, W.-Y., Yen, K.-C., Yang, K.-C., & Lin, F.-H. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.03.010 · Cited by 260
Heister, E., Neves, V., Tîlmaciu, C., Lipert, K., Beltrán, V. S., Coley, H. M., Silva, S. R. P., & McFadden, J. (2009) · Carbon · doi:10.1016/j.carbon.2009.03.057 · Cited by 259
Bio-distribution, toxicity and pathology of cowpea mosaic virus nanoparticles in vivo
Singh, P., Prasuhn, D., Yeh, R. M., Destito, G., Rae, C. S., Osborn, K., Finn, M. G., & Manchester, M. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.04.003 · Cited by 254
Patlolla, R. R., Chougule, M., Patel, A. R., Jackson, T., Tata, P. N. V., & Singh, M. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.02.006 · Cited by 250
Potentials of new nanocarriers for dermal and transdermal drug delivery
Neubert, R. H. H. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.11.003 · Cited by 250
de Groot, F. M. H., Albrecht, C., Koekkoek, R., Beusker, P. H., & Scheeren, H. W. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200351942 · Cited by 247
Covalently Combining Carbon Nanotubes with Anticancer Agent: Preparation and Antitumor Activity
Wu, W., Li, R., Bian, X., Zhu, Z., Ding, D., Li, X., Jia, Z., Jiang, X., & Hu, Y. (2009) · ACS Nano · doi:10.1021/nn9005686 · Cited by 247
Taratula, O., Garbuzenko, O. B., Chen, A. M., & Minko, T. (2011) · Journal of Drug Targeting · doi:10.3109/1061186x.2011.622404 · Cited by 245
Lai, P.-S., Lou, P.-J., Peng, C.-L., Pai, C.-L., Yen, W.-N., Huang, M.-Y., Young, T.-H., & Shieh, M.-J. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.06.012 · Cited by 240
Ajima, K., Murakami, T., Mizoguchi, Y., Tsuchida, K., Ichihashi, T., Iijima, S., & Yudasaka, M. (2008) · ACS Nano · doi:10.1021/nn800395t · Cited by 240
Polymeric Micelles: Recent Advancements in the Delivery of Anticancer Drugs
Gothwal, A., Khan, I., & Gupta, U. (2016) · Pharmaceutical Research · doi:10.1007/s11095-015-1784-1 · Cited by 233
Advances of Cancer Therapy by Nanotechnology
Wang, X., Wang, Y., Chen, Z. G., & Shin, D. M. (2009) · Cancer Research and Treatment · doi:10.4143/crt.2009.41.1.1 · Cited by 230
Lu, Y.-J., Wei, K.-C., Ma, C.-C. M., Yang, S.-Y., & Chen, J.-P. (2012) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2011.08.001 · Cited by 223
FDA Drug Approval Summary: Bevacizumab Plus FOLFOX4 as Second-Line Treatment of Colorectal Cancer
Cohen, M. H., Gootenberg, J., Keegan, P., & Pazdur, R. (2007) · The Oncologist · doi:10.1634/theoncologist.12-3-356 · Cited by 217
Small-molecule delivery by nanoparticles for anticancer therapy
Chen, Z. (. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.08.001 · Cited by 212
Nanoparticulate Alternatives for Drug Delivery
Adair, J. H., Parette, M. P., Altınoğlu, E. İ., & Kester, M. (2010) · ACS Nano · doi:10.1021/nn102324e · Cited by 208
Gan, C. W., & Feng, S.-S. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.06.053 · Cited by 207
Ji, Z., Lin, G., Lu, Q., Meng, L., Shen, X., Dong, L., Fu, C., & Zhang, X. (2012) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2011.09.013 · Cited by 205
Potineni, A., Lynn, D. M., Langer, R., & Amiji, M. M. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00374-7 · Cited by 201
Abner, A. L., Recht, A., Eberlein, T., Come, S., Shulman, L., Hayes, D., Connolly, J. L., Schnitt, S. J., Silver, B., & Harris, J. R. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.1.44 · Cited by 200
Materializing the Potential of Small Interfering RNA via a Tumor-Targeting Nanodelivery System
Pirollo, K. F., Rait, A., Zhou, Q., Hwang, S. H., Dagata, J. A., Zon, G., Hogrefe, R. I., Palchik, G., & Chang, E. H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4535 · Cited by 195
Lu, J., Liong, M., Sherman, S., Xia, T., Kovochich, M., Nel, A. E., Zink, J. I., & Tamanoi, F. (2007) · NanoBiotechnology · doi:10.1007/s12030-008-9003-3 · Cited by 192
Lay, C. L., Liu, H. Q., Tan, H. R., & Liu, Y. (2010) · Nanotechnology · doi:10.1088/0957-4484/21/6/065101 · Cited by 190
Optimization of 5-fluorouracil solid-lipid nanoparticles: a preliminary study to treat colon cancer
Yassin, A. E. B., Anwer, M. K., Mowafy, H. A., El-Bagory, I. M., Bayomi, M. A., & Alsarra, I. A. (2010) · International Journal of Medical Sciences · doi:10.7150/ijms.7.398 · Cited by 188
Rosenholm, J. M., Peuhu, E., Bate‐Eya, L. T., Eriksson, J. E., Sahlgren, C., & Lindén, M. (2010) · Small · doi:10.1002/smll.200902355 · Cited by 186
Nano- and micro-based inhaled drug delivery systems for targeting alveolar macrophages
Lee, W.-H., Loo, C.-Y., Traini, D., & Young, P. M. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.1039509 · Cited by 179
Towards the preparative and large-scale precision manufacture of virus-like particles
Pattenden, L. K., Middelberg, A. P. J., Niebert, M., & Lipin, D. I. (2005) · Trends in Biotechnology · doi:10.1016/j.tibtech.2005.07.011 · Cited by 177
Carbon nanotubes for the delivery of therapeutic molecules
Bianco, A. (2004) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.1.1.57 · Cited by 176
Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles
AZARMI, S., TAO, X., CHEN, H., WANG, Z., FINLAY, W., LOBENBERG, R., & ROA, W. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.03.052 · Cited by 169
Muller, R. H., Radtke, M., & Wissing, S. A. (2003) · ChemInform · doi:10.1002/chin.200335261 · Cited by 164
Milane, L., Duan, Z., & Amiji, M. (2011) · Molecular Pharmaceutics · doi:10.1021/mp1002653 · Cited by 161
Anitha, A., Deepa, N., Chennazhi, K. P., Lakshmanan, V.-K., & Jayakumar, R. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.06.004 · Cited by 158
Applications of Nanoparticles for Anticancer Drug Delivery: A Review
Zhu, Y., & Liao, L. (2014) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2015.10298 · Cited by 157
Samorì, C., Ali‐Boucetta, H., Sainz, R., Guo, C., Toma, F. M., Fabbro, C., Ros, T. D., Prato, M., Kostarelos, K., & Bianco, A. (2009) · Chemical Communications · doi:10.1039/b923560d · Cited by 152
Karthikeyan, S., Prasad, N. R., Ganamani, A., & Balamurugan, E. (2012) · Biomedicine & Preventive Nutrition · doi:10.1016/j.bionut.2012.10.009 · Cited by 152
How, C. W., Abdullah, R., Manickam, S., & Rosli, R. (2013) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2013.08.009 · Cited by 145
Curcumin-containing chitosan nanoparticles as a potential mucoadhesive delivery system to the colon
Chuah, L., Billa, N., Roberts, C. J., Burley, J., & Manickam, S. (2011) · Pharmaceutical Development and Technology · doi:10.3109/10837450.2011.640688 · Cited by 142
Nanotechnology: from In Vivo Imaging System to Controlled Drug Delivery
Mir, M., Ishtiaq, S., Rabia, S., Khatoon, M., Zeb, A., Khan, G. M., Rehman, A. U., & Din, F. U. (2017) · Nanoscale Research Letters · doi:10.1186/s11671-017-2249-8 · Cited by 141
Self-citationDas, M., Datir, S. R., Singh, R. P., & Jain, S. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300701e · Cited by 134
Han, N., Zhao, Q., Wan, L., Wang, Y., Gao, Y., Wang, P., Wang, Z., Zhang, J., Jiang, T., & Wang, S. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/am5082793 · Cited by 121
Canine parvovirus-like particles, a novel nanomaterial for tumor targeting
Singh, P. N. P., Destito, G., Schneemann, A., & Manchester, M. (2006) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-4-2 · Cited by 120
Lebold, T., Jung, C., Michaelis, J., & Bräuchle, C. (2009) · Nano Letters · doi:10.1021/nl9011112 · Cited by 115
Song, Z., Lin, Y., Zhang, X., Feng, C., Lu, Y., Gao, Y., & Dong, C. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s125573 · Cited by 114
Khuroo, T., Verma, D., Talegaonkar, S., Padhi, S., Panda, A. K., & Iqbal, Z. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.07.022 · Cited by 113
Muthoosamy, K., Abubakar, I. B., Bai, R. G., Loh, H., & Manickam, S. (2016) · Scientific Reports · doi:10.1038/srep32808 · Cited by 110
Rapid Photothermal Intracellular Drug Delivery Using Multiwalled Carbon Nanotubes
Levi‐Polyachenko, N. H., Merkel, E., Jones, B. T., Carroll, D., & Stewart, J. H. (2009) · Molecular Pharmaceutics · doi:10.1021/mp800250e · Cited by 109
Are We Finally Winning the War on Cancer?
Cutler, D. (2008) · The Journal of Economic Perspectives · doi:10.1257/jep.22.4.3 · Cited by 108
Smart Mesoporous Nanomaterials for Antitumor Therapy
Martínez‐Carmona, M., Colilla, M., & Vallet‐Regí, M. (2015) · Nanomaterials · doi:10.3390/nano5041906 · Cited by 103
9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice.
Koshkina, N. V., Kleinerman, E. S., Waidrep, C., Jia, S.-F., Worth, L. L., Gilbert, B. E., & Knight, V. (2000) · PubMed · Cited by 101
Alginate/CaCO3 Hybrid Nanoparticles for Efficient Codelivery of Antitumor Gene and Drug
Zhao, D. M., Liu, C., Zhuo, R., & Cheng, S. (2012) · Molecular Pharmaceutics · doi:10.1021/mp3002123 · Cited by 100
Battaglia, L., Gallarate, M., Peira, E., Chirio, D., Muntoni, E., Biasibetti, E., Capucchio, M. T., Valazza, A., Panciani, P. P., Lanotte, M., et al. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24002 · Cited by 98
Cabral, H., Murakami, M., Hojo, H., Terada, Y., Kano, M. R., Chung, U., Nishiyama, N., & Kataoka, K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301348110 · Cited by 92
Li, X., Yang, Z., Yang, K., Zhou, Y., Chen, X., Zhang, Y., Wang, F., Liu, Y., & Ren, L. (2009) · Nanoscale Research Letters · doi:10.1007/s11671-009-9427-2 · Cited by 91
Cao, J., Guenther, R. H., Sit, T. L., Opperman, C., Lommel, S. A., & Crowe, J. A. (2014) · Small · doi:10.1002/smll.201400558 · Cited by 85
Patel, M., Lakkadwala, S., Majrad, M. S., Injeti, E. R., Gollmer, S. M., Shah, Z. A., Boddu, S. H. S., & Nesamony, J. (2014) · AAPS PharmSciTech · doi:10.1208/s12249-014-0168-x · Cited by 75
Delivery of carboplatin by carbon-based nanocontainers mediates increased cancer cell death
Arlt, M., Haase, D., Hampel, S., Oswald, S., Bachmatiuk, A., Klingeler, R., Schulze, R., Ritschel, M., Leonhardt, A., Fuessel, S., et al. (2010) · Nanotechnology · doi:10.1088/0957-4484/21/33/335101 · Cited by 75
Faraj, A. A., Shaik, A. S., Ratemi, E., & Halwani, R. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.053 · Cited by 74
Jinturkar, K., Anish, C., Kumar, M., Bagchi, T., Panda, A. K., & Misra, A. R. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.067 · Cited by 71
Targeting Cancer Cells with Dendrimers
Sampathkumar, S., & Yarema, K. J. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.12.007 · Cited by 70
Hyaluronic acid-tagged silica nanoparticles in colon cancer therapy: therapeutic efficacy evaluation
Huo, Z., Liu, K., Wang, Z., Wang, S.-J., Liu, P., Qin, Y., Ma, Y., & Li, X. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s89476 · Cited by 69
Hitzman, C. J., Wattenberg, L. W., & Wiedmann, T. S. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20607 · Cited by 68
Silencing microRNA by interfering nanoparticles in mice
Su, J., Baigude, H., McCarroll, J., & Rana, T. M. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1307 · Cited by 64
Prabhakar, N., Zhang, J., Desai, D., Casals, E., Gulin-Sarfraz, T., Näreoja, T., Westermarck, J. K., & Rosenholm, J. M. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s120611 · Cited by 63
Kim, J., Kim, Y., Bae, K. H., Park, T. G., Lee, J. H., & Park, K. (2015) · Molecular Pharmaceutics · doi:10.1021/mp500737y · Cited by 61
Adeli, M., Hakimpoor, F., Ashiri, M., Kabiri, R., & Bavadi, M. (2011) · Soft Matter · doi:10.1039/c0sm01550d · Cited by 60
Recent Advances in Carbon Nanotubes as Delivery Systems for Anticancer Drugs
Iannazzo, D., Piperno, A., Pistone, A., Grassi, G., & Galvagno, S. (2013) · Current Medicinal Chemistry · doi:10.2174/0929867311320110001 · Cited by 57
Poly(lactic acid)/chitosan hybrid nanoparticles for controlled release of anticancer drug
Wang, W., Chen, S., Zhang, L., Wu, X., Wang, J., Chen, J., & Le, Y. (2014) · Materials Science and Engineering C · doi:10.1016/j.msec.2014.10.048 · Cited by 56
Development of docetaxel nanocrystals surface modified with transferrin for tumor targeting
Choi, J., & Park, J. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s122984 · Cited by 56
Zuur, C. L., Simis, Y. J. W., Verkaik, R. S., Schornagel, J. H., Balm, A. J. M., Dreschler, W. A., & Rasch, C. R. N. (2008) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2008.06.003 · Cited by 55
Aptamer-labeled PLGA nanoparticles for targeting cancer cells
Aravind, A., Varghese, S. H., Veeranarayanan, S., Mathew, A., Nagaoka, Y., Iwai, S., Fukuda, T., Hasumura, T., Yoshida, Y., Maekawa, T., et al. (2012) · Cancer Nanotechnology · doi:10.1007/s12645-011-0024-6 · Cited by 53
Lin, C. J., Yang, T.-Y., Lee, C., et al. (2009) · Cited by 52
Use of Targeted Liposome-based Chemotherapeutics to Treat Breast Cancer
Khan, D. R., Webb, M. N., Cadotte, T. H., & Gavette, M. N. (2015) · Breast Cancer Basic and Clinical Research · doi:10.4137/bcbcr.s29421 · Cited by 47
Cohen, S. M., Mukerji, R., Cai, S., et al. (2011) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2011.06.027 · Cited by 45
Zeb, A., Qureshi, O. S., Kim, H.-S., Kim, M.-S., Kang, J.-H., Park, J., & Kim, J. (2017) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12727 · Cited by 45
Self-citationOcular adverse effects of Anti-cancer Chemotherapy
Singh, P., & Singh, A. K. (2012) · journal of cancer therapeutics and research · doi:10.7243/2049-7962-1-5 · Cited by 37
de Groot, F. M. H., Albrecht, C., Koekkoek, R., Beusker, P. H., & Scheeren, H. W. (2003) · Angewandte Chemie · doi:10.1002/ange.200351942 · Cited by 37
Wu, W., Jing, Zheng, Z., Huang, Liu, Hu, Liu, Wang, Yue, Y., & Tong (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s32620 · Cited by 30
Anderson, D. C., Najafzadeh, M., Gopalan, R. C., Ghaderi, N., Scally, A., Britland, S. T., Jacobs, B. K., Reynolds, P., Davies, J. D., Wright, A. L., et al. (2014) · The FASEB Journal · doi:10.1096/fj.14-254748 · Cited by 28
Patient selection and targeted treatment in the management of platinum-resistant ovarian cancer
Leamon, C., Lovejoy, & Nguyen, N. T. (2013) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s24943 · Cited by 27
Polymeric Systems Incorporating Plant Viral Nanoparticles for Tailored Release of Therapeutics
Honarbakhsh, S., Guenther, R. H., Crowe, J. A., Lommel, S. A., & Pourdeyhimi, B. (2013) · Advanced Healthcare Materials · doi:10.1002/adhm.201200434 · Cited by 26
Oxaliplatin loaded PLAGA microspheres:
Lagarce, F., Cruaud, O., Deuschel, C., Bayssas, M., Griffon, G., & Benoît, J. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00166-7 · Cited by 25
Manickam, S., Ng, C. M., Loh, H., Muthoosamy, K., & Sridewi, N. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s98726 · Cited by 24
Cited by
Therapeutic Nanoparticles and Their Targeted Delivery Applications
Yetisgin, A. A., Cetinel, S., Zuvin, M., Kosar, A., & Kutlu, O. (2020) · Molecules · doi:10.3390/molecules25092193 · Cited by 1,080
Breast cancer: Biology, biomarkers, and treatments
Barzaman, K., Karami, J., Zarei, Z., Hosseinzadeh, A., Kazemi, M. H., Moradi-Kalbolandi, S., Safari, E., & Farahmand, L. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106535 · Cited by 973
Lombardo, D., Kiselev, M. A., & Caccamo, M. T. (2019) · Journal of Nanomaterials · doi:10.1155/2019/3702518 · Cited by 864
Porous scaffolds for bone regeneration
Abbasi, N., Hamlet, S., Love, R. M., & Nguyen, N.-T. (2020) · Journal of Science: Advanced Materials and Devices · doi:10.1016/j.jsamd.2020.01.007 · Cited by 858
Recent advances in polymeric drug delivery systems
Sung, Y. K., & Kim, S. W. (2020) · Biomaterials Research · doi:10.1186/s40824-020-00190-7 · Cited by 732
Metadata
- Authors
- Din, F. U., Aman, W., Ullah, I., Qureshi, O. S., Mustapha, O., Shafique, S., & Zeb, A.
- Venue
- International Journal of Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2017-10
- Volume
- Volume 12
- Pages
- 7291-7309
- ISSN
- 1176-9114 (ISSN-L)
- 1178-2013
- OpenAlex
- W2762341360
- Cited by
- 1,577
- References
- 165
- FWCI
- 27.18
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.